Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study
Arya M. SharmaMcMaster University, Hamilton, ON, CanadaTodd H. WagnerLilly Deutschland GmbH, Bad Homburg, GermanyP MarsalekLilly Deutschland GmbH, Bad Homburg, Germany
2004en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references